CICON23. Seventh International Cancer Immunotherapy Conference: Translating Science into Survival

CICON23. Seventh International Cancer Immunotherapy Conference: Translating Science into Survival

Milan

especialistas del campo de la inmuno oncología

European Network for Cancer Immunotherapy (ENCI), Cancer Research Institute (CRI) y American Association for Cancer Research (AACR

Pier Francesco Ferrucci, Istituto Europeo di Oncologia, Milan, Italy

Christoph Huber, Association for Cancer Immunotherapy, Mainz, Germany

Padmanee Sharma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA

Arlene H. Sharpe, Harvard Medical School, Boston, MA, USA

Mustafa Diken, Johannes Gutenberg University, Mainz, Germany

Marina Garassino, University of Chicago, Chicago, IL, USA

Nir Hacohen, Broad Institute of MIT and Harvard; Massachusetts General Hospital, Boston, MA, USA

Susan M. Kaech, The Salk Institute for Biological Studies, La Jolla, CA, USA

Paola Nisticò, Regina Elena National Cancer Institute, Rome, Italy

Pamela S. Ohashi, University of Toronto, Toronto, Canada

Catherine Sautès-Fridman, University Paris-Descartes, Paris, France

Andrea Schietinger, Memorial Sloan Kettering Cancer Center, New York, NY, USA

Özlem Türeci, BioNTech SE, Mainz, Germany

Cassian Yee, The University of Texas MD Anderson Cancer Center, Houston, TX, USA

Laurence Zitvogel, Gustave Roussy Institute, Villejuif, France

info@cancerimmunotherapyconference.org

http://www.cancerimmunotherapyconference.org/